Symptoms and Quality of Life in Late Stage Parkinson Syndromes: A Longitudinal Community Study of Predictive Factors

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Higginson, Irene J ^a   Gao, Wei ^a   Saleem, Tariq Zaffer ^a   Chaudhuri, K Ray ^a,b   Burman, Rachel ^a   McCrone, Paul ^a   Leigh, Peter Nigel ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COMMUNITY; DEATH; DEMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; FACTORIAL ANALYSIS; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC DISEASE; IDIOPATHIC PARKINSON DISEASE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PALLIATIVE CARE OUTCOME SCALE; PALLIATIVE THERAPY; PARKINSON DISEASE; PARKINSONISM; PHYSICAL DISABILITY; PREDICTION; PROGRESSIVE SUPRANUCLEAR PALSY; QUALITY OF LIFE; RATING SCALE; SELF REPORT; SHY DRAGER SYNDROME; SYMPTOM; WHEELCHAIR;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PALLIATIVE CARE; PARKINSONIAN DISORDERS; PROGNOSIS; QUALITY OF LIFE; SEX FACTORS;

EID: 84868705082     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046327     Document Type: Article

References (48)

1. Karlsen KH, Tandberg E, Arsland D, Larsen JP, (2000) Health related quality of life in Parkinson's disease: a prospective longitudinal study. J Neurol Neurosurg Psychiatry 69: 584-589.
2. Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri KR, (2011) The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease. Mov Disord 26: 399-406 10.1002/mds.23462 [doi].
3. Stefanova N, Bucke P, Duerr S, Wenning GK, (2009) Multiple system atrophy: an update. Lancet Neurol 8: 1172-1178 S1474-4422(09)70288-1 [pii];10.1016/S1474-4422(09)70288-1 [doi].
4. Wenning GK, Stefanova N, (2009) Recent developments in multiple system atrophy. J Neurol 256: 1791-1808 10.1007/s00415-009-5173-8 [doi].
5. McCrone P, Payan CA, Knapp M, Ludolph A, Agid Y, et al. (2011) The economic costs of progressive supranuclear palsy and multiple system atrophy in France, Germany and the United Kingdom. PLoS One 6: e24369 10.1371/journal.pone.0024369 [doi];PONE-D-11-11849 [pii].
6. Schenkman M, Wei ZC, Cutson TM, Whetten-Goldstein K, (2001) Longitudinal evaluation of economic and physical impact of Parkinson's disease. Parkinsonism Relat Disord 8: 41-50 S1353-8020(00)00079-1 [pii].
7. de Boer AG, Sprangers MA, Speelman HD, de Haes HC, (1999) Predictors of health care use in patients with Parkinson's disease: a longitudinal study. Mov Disord 14: 772-779.
8. Brown RG, Lacomblez L, Landwehrmeyer BG, Bak T, Uttner I, et al. (2010) Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain 133: 2382-2393 awq158 [pii];10.1093/brain/awq158 [doi].
9. Visser M, Verbaan D, van RS, Marinus J, van HJ, Stiggelbout A, (2009) A longitudinal evaluation of health-related quality of life of patients with Parkinson's disease. Value Health 12: 392-396 S1098-3015(10)60720-6 [pii];10.1111/j.1524-4733.2008.00430.x [doi].
10. Dibble LE, Cavanaugh JT, Earhart GM, Ellis TD, Ford MP, Foreman KB, (2010) Charting the progression of disability in Parkinson disease: study protocol for a prospective longitudinal cohort study. BMC Neurol 10: 110 1471-2377-10-110 [pii];10.1186/1471-2377-10-110 [doi].
11. Grosset D, Taurah L, Burn DJ, MacMahon D, Forbes A, et al. (2007) A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson's disease left untreated at diagnosis. J Neurol Neurosurg Psychiatry 78: 465-469 jnnp.2006.098327 [pii];10.1136/jnnp.2006.098327 [doi].
12. Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN, (2009) Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain 132: 156-171 awn291 [pii];10.1093/brain/awn291 [doi].
13. Payan CA, Viallet F, Landwehrmeyer BG, Bonnet AM, Borg M, et al. (2011) Disease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS-Parkinson Plus Scale. PLoS One 6: e22293 10.1371/journal.pone.0022293 [doi];PONE-D-11-04618 [pii].
14. Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, Mitra T, Frades-Payo B, et al. (2010) The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord 25: 704-709 10.1002/mds.22868 [doi].
15. Mitsumoto H, Rabkin JG, (2007) Palliative care for patients with amyotrophic lateral sclerosis: "prepare for the worst and hope for the best". JAMA 298: 207-216 298/2/207 [pii];10.1001/jama.298.2.207 [doi].
16. Gomes B, Higginson IJ, (2008) Where people die (1974-2030): past trends, future projections and implications for care. Palliat Med 22: 33-41 22/1/33 [pii];10.1177/0269216307084606 [doi].
17. Shipman C, Gysels M, White P, Worth A, Murray SA, et al. (2008) Improving generalist end of life care: national consultation with practitioners, commissioners, academics, and service user groups. BMJ 337: a1720.
18. Bausewein C, Booth S, Gysels M, Kuhnbach R, Haberland B, Higginson IJ, (2010) Individual breathlessness trajectories do not match summary trajectories in advanced cancer and chronic obstructive pulmonary disease: results from a longitudinal study. Palliat Med 24: 777-786 0269216310378785 [pii];10.1177/0269216310378785 [doi].
19. Murtagh FE, Sheerin NS, Addington-Hall J, Higginson IJ, (2011) Trajectories of illness in stage 5 chronic kidney disease: a longitudinal study of patient symptoms and concerns in the last year of life. Clin J Am Soc Nephrol 6: 1580-1590 CJN.09021010 [pii];10.2215/CJN.09021010 [doi].
20. Solano JP, Gomes B, Higginson IJ, (2006) A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage 31: 58-69 S0885-3924(05)00561-0 [pii];10.1016/j.jpainsymman.2005.06.007 [doi].
21. Saleem T, Leigh PN, Higginson IJ, (2007) Symptom prevalence among people affected by advanced and progressive neurological conditions-a systematic review. J Palliat Care 23: 291-299.
22. Hoehn MM, Yahr MD, (1967) Parkinsonism: onset, progression and mortality. Neurology 17: 427-442.
23. Hearn J, Higginson IJ, (1999) Development and validation of a core outcome measure for palliative care: the palliative care outcome scale. Palliative Care Core Audit Project Advisory Group. Qual Health Care 8: 219-227.
24. Higginson IJ, Hart S, Silber E, Burman R, Edmonds P, (2006) Symptom prevalence and severity in people severely affected by multiple sclerosis. J Palliat Care 22: 158-165.
25. Mitchell SL, Kiely DK, Miller SC, Connor SR, Spence C, Teno JM, (2007) Hospice care for patients with dementia. J Pain Symptom Manage 34: 7-16 S0885-3924(07)00262-X [pii];10.1016/j.jpainsymman.2007.01.003 [doi].
26. Hanratty B, Burstrom B, Walander A, Whitehead M, (2007) Inequality in the face of death? Public expenditure on health care for different socioeconomic groups in the last year of life. J Health Serv Res Policy 12: 90-94 10.1258/135581907780279585 [doi].
27. Rolls L, Seymour JE, Froggatt KA, Hanratty B, (2011) Older people living alone at the end of life in the U.K.: research and policy challenges. Palliat Med 25: 650-657 0269216310373165 [pii];10.1177/0269216310373165 [doi].
28. Mitchell SL, Black BS, Ersek M, Hanson LC, Miller SC, et al. (2012) Advanced dementia: state of the art and priorities for the next decade. Ann Intern Med 156: 45-51 156/1_Part_1/45 [pii];10.1059/0003-4819-156-1-201201030-00008 [doi].
29. Higginson IJ, McCrone P, Hart SR, Burman R, Silber E, Edmonds PM, (2009) Is short-term palliative care cost-effective in multiple sclerosis? A randomized phase II trial. J Pain Symptom Manage 38: 816-826 S0885-3924(09)00741-6 [pii];10.1016/j.jpainsymman.2009.07.002 [doi].
30. Higginson IJ, Costantini M, Silber E, Burman R, Edmonds P, (2011) Evaluation of a new model of short-term palliative care for people severely affected with multiple sclerosis: a randomised fast-track trial to test timing of referral and how long the effect is maintained. Postgrad Med J 87: 769-775 postgradmedj-2011-130290 [pii];10.1136/postgradmedj-2011-130290 [doi].
31. Buecken R, Galushko M, Golla H, Strupp J, Hahn M, et al. (2012) Patients feeling severely affected by multiple sclerosis: How do patients want to communicate about end-of-life issues? Patient Educ Couns S0738-3991(12)00123-1 [pii];10.1016/j.pec.2012.03.010 [doi].
32. Voltz R, Borasio GD, (1997) Palliative therapy in the terminal stage of neurological disease. J Neurol 244 Suppl 4: S2-10.
33. Peto V, Jenkinson C, Fitzpatrick R, (1998) PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures. J Neurol 245 Suppl 1: S10-S14.
34. Huang TT, Hsu HY, Wang BH, Chen KH, (2011) Quality of life in Parkinson's disease patients: validation of the Short-Form Eight-item Parkinson's Disease Questionnaire (PDQ-8) in Taiwan. Qual Life Res 20: 499-505 10.1007/s11136-010-9777-3 [doi].
35. Katsarou Z, Bostantjopoulou S, Peto V, Kafantari A, Apostolidou E, Peitsidou E, (2004) Assessing quality of life in Parkinson's disease: can a short-form questionnaire be useful? Mov Disord 19: 308-312 10.1002/mds.10678 [doi].
36. Menza M, Dobkin RD, Marin H, Mark MH, Gara M, et al. (2009) The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease. Mov Disord 24: 1325-1332 10.1002/mds.22586 [doi].
37. Cheung YB, Tan LC, Lau PN, Au WL, Luo N, (2008) Mapping the eight-item Parkinson's Disease Questionnaire (PDQ-8) to the EQ-5D utility index. Qual Life Res 17: 1173-1181 10.1007/s11136-008-9392-8 [doi].
38. Luo N, Ng WY, Lau PN, Au WL, Tan LC, (2010) Responsiveness of the EQ-5D and 8-item Parkinson's Disease Questionnaire (PDQ-8) in a 4-year follow-up study. Qual Life Res 19: 565-569 10.1007/s11136-010-9615-7 [doi].
39. Forjaz MJ, Rodriguez-Blazquez C, Martinez-Martin P, (2009) Rasch analysis of the hospital anxiety and depression scale in Parkinson's disease. Mov Disord 24: 526-532 10.1002/mds.22409 [doi].
40. Rodriguez-Blazquez C, Frades-Payo B, Forjaz MJ, de Pedro-Cuesta J, Martinez-Martin P, (2009) Psychometric attributes of the Hospital Anxiety and Depression Scale in Parkinson's disease. Mov Disord 24: 519-525 10.1002/mds.22321 [doi].
41. Schrag A, Spottke A, Quinn NP, Dodel R, (2009) Comparative responsiveness of Parkinson's disease scales to change over time. Mov Disord 24: 813-818 10.1002/mds.22438 [doi].
42. Marinus J, Ramaker C, van Hilten JJ, Stiggelbout AM, (2002) Health related quality of life in Parkinson's disease: a systematic review of disease specific instruments. J Neurol Neurosurg Psychiatry 72: 241-248.
43. Schrag A, Selai C, Jahanshahi M, Quinn NP, (2000) The EQ-5D-a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 69: 67-73.
44. Dolan P, (1997) Modeling valuations for EuroQol health states. Med Care 35: 1095-1108.
45. Bausewein C, Le GC, Simon S, Higginson I, (2011) The use of two common palliative outcome measures in clinical care and research: a systematic review of POS and STAS. Palliat Med 25: 304-313 0269216310395984 [pii];10.1177/0269216310395984 [doi].
46. Brandt HE, Deliens L, van der Steen JT, Ooms ME, Ribbe MW, van der Wal G, (2005) The last days of life of nursing home patients with and without dementia assessed with the palliative care outcome scale. Palliat Med 19: 334-342.
47. Higginson IJ, Gao W, (2008) Caregiver assessment of patients with advanced cancer: concordance with patients, effect of burden and positivity. Health Qual Life Outcomes 6: 42 1477-7525-6-42 [pii];10.1186/1477-7525-6-42 [doi].
48. Siegert RJ, Gao W, Walkey FH, Higginson IJ, (2010) Psychological well-being and quality of care: a factor-analytic examination of the palliative care outcome scale. J Pain Symptom Manage 40: 67-74 S0885-3924(10)00277-0 [pii];10.1016/j.jpainsymman.2009.11.326 [doi].